Post-marketing Surveillance of Linaclotide Tablet in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation (Excluding Constipation Due to Organic Diseases)

Clinical trial NCT03471728 · COMPLETED

Trial details

NCT number: NCT03471728
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Constipation (CC) (Excluding Constipation Due to Organic Diseases)Irritable Bowel Syndrome With Constipation (IBS-C)

Start date: 2017-10-02
Primary completion: 2021-12-31
Enrollment: 2475

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.